{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T14:08:49Z","timestamp":1791554929227,"version":"4.3.4"},"reference-count":135,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T00:00:00Z","timestamp":1743897600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T00:00:00Z","timestamp":1743897600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Ther"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s40120-025-00737-7","type":"journal-article","created":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T15:03:51Z","timestamp":1743951831000},"page":"711-731","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["The Kappa Free Light Chains Index and Central Vein Sign: Two New Biomarkers for Multiple Sclerosis Diagnosis"],"prefix":"10.1007","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5611-212X","authenticated-orcid":false,"given":"Michael","family":"Levraut","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassandre","family":"Landes-Chateau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydiane","family":"Mondot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikael","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Lebrun-Frenay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,6]]},"reference":[{"issue":"2","key":"737_CR1","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","volume":"17","author":"AJ Thompson","year":"2018","unstructured":"Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018;17(2):162\u201373.","journal-title":"Lancet Neurol"},{"key":"737_CR2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000013016","author":"M Filippi","year":"2022","unstructured":"Filippi M, Preziosa P, Meani A, Dalla Costa G, Mesaros S, Drulovic J, et al. Performance of the 2017 and 2010 revised McDonald criteria in predicting MS diagnosis after a clinically isolated syndrome: a MAGNIMS study. Neurology [Internet]. 2022. https:\/\/doi.org\/10.1212\/WNL.0000000000013016.","journal-title":"Neurology [Internet]"},{"issue":"2","key":"737_CR3","doi-asserted-by":"publisher","first-page":"e528","DOI":"10.1212\/NXI.0000000000000528","volume":"6","author":"YYM Wong","year":"2019","unstructured":"Wong YYM, De Mol CL, Der Vuurst V, De Vries RM, Van Pelt ED, Ketelslegers IA, Catsman-Berrevoets CE, et al. Real-world validation of the 2017 McDonald criteria for pediatric MS. Neurol Neuroimmunol Neuroinflamm. 2019;6(2):e528.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"11","key":"737_CR4","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1001\/jamaneurol.2018.2160","volume":"75","author":"V Der Vuurst","year":"2018","unstructured":"Der Vuurst V, De Vries RM, Mescheriakova JY, Wong YYM, Runia TF, Jafari N, Samijn JP, et al. Application of the 2017 revised McDonald criteria for multiple sclerosis to patients with a typical clinically isolated syndrome. JAMA Neurol. 2018;75(11):1392.","journal-title":"JAMA Neurol"},{"issue":"1","key":"737_CR5","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1212\/WNL.0000000000006583","volume":"92","author":"AJ Solomon","year":"2019","unstructured":"Solomon AJ, Naismith RT, Cross AH. Misdiagnosis of multiple sclerosis: Impact of the 2017 McDonald criteria on clinical practice. Neurology. 2019;92(1):26\u201333.","journal-title":"Neurology"},{"issue":"9","key":"737_CR6","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1212\/01.wnl.0000335764.14513.1a","volume":"72","author":"DT Okuda","year":"2009","unstructured":"Okuda DT, Mowry EM, Beheshtian A, Waubant E, Baranzini SE, Goodin DS, et al. Incidental MRI anomalies suggestive of multiple sclerosis: the radiologically isolated syndrome. Neurology. 2009;72(9):800\u20135.","journal-title":"Neurology"},{"issue":"3","key":"737_CR7","doi-asserted-by":"publisher","first-page":"e90509","DOI":"10.1371\/journal.pone.0090509","volume":"9","author":"DT Okuda","year":"2014","unstructured":"Okuda DT, Siva A, Kantarci O, Inglese M, Katz I, Tutuncu M, et al. Radiologically isolated syndrome: 5-year risk for an initial clinical event. Jacobson S, \u00e9diteur. PLoS ONE. 2014;9(3):e90509.","journal-title":"PLoS ONE"},{"issue":"2","key":"737_CR8","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1002\/ana.25799","volume":"88","author":"C Lebrun-Frenay","year":"2020","unstructured":"Lebrun-Frenay C, Kantarci O, Siva A, Sormani MP, Pelletier D, Okuda DT, et al. Radiologically isolated syndrome: 10-year risk estimate of a clinical event. Ann Neurol. 2020;88(2):407\u201317.","journal-title":"Ann Neurol"},{"issue":"10","key":"737_CR9","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.28271","volume":"4","author":"C Lebrun-Fr\u00e9nay","year":"2021","unstructured":"Lebrun-Fr\u00e9nay C, Rollot F, Mondot L, Zephir H, Louapre C, Le Page E, et al. Risk factors and time to clinical symptoms of multiple sclerosis among patients with radiologically isolated syndrome. JAMA Netw Open. 2021;4(10): e2128271.","journal-title":"JAMA Netw Open"},{"issue":"3","key":"737_CR10","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1002\/ana.26555","volume":"93","author":"DT Okuda","year":"2023","unstructured":"Okuda DT, Kantarci O, Lebrun-Fr\u00e9nay C, Sormani MP, Azevedo CJ, Bovis F, et al. Dimethyl fumarate delays multiple sclerosis in radiologically isolated syndrome. Ann Neurol. 2023;93(3):604\u201314.","journal-title":"Ann Neurol"},{"issue":"10","key":"737_CR11","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1001\/jamaneurol.2023.2815","volume":"80","author":"C Lebrun-Fr\u00e9nay","year":"2023","unstructured":"Lebrun-Fr\u00e9nay C, Siva A, Sormani MP, Landes-Chateau C, Mondot L, Bovis F, et al. Teriflunomide and time to clinical multiple sclerosis in patients with radiologically isolated syndrome: the TERIS randomized clinical trial. JAMA Neurol. 2023;80(10):1080.","journal-title":"JAMA Neurol"},{"issue":"8","key":"737_CR12","doi-asserted-by":"publisher","first-page":"3431","DOI":"10.1093\/brain\/awad073","volume":"146","author":"C Lebrun-Fr\u00e9nay","year":"2023","unstructured":"Lebrun-Fr\u00e9nay C, Okuda DT, Siva A, Landes-Chateau C, Azevedo CJ, Mondot L, et al. The radiologically isolated syndrome: revised diagnostic criteria. Brain. 2023;146(8):3431\u201343.","journal-title":"Brain"},{"key":"737_CR13","unstructured":"Montalban X. 2024 revisions of the McDonald criteria [Internet]. ECTRIMS\/EAN; 2024. Disponible sur: https:\/\/view.officeapps.live.com\/op\/view.aspx?src=https%3A%2F%2Fectrims.eu%2Fapp%2Fuploads%2F2024%2F10%2F2024_McDonald_Criteria_ECTRIMS.XM_.FINAL_.pptx&wdOrigin=BROWSELINK. Accessed Sept 2024."},{"key":"737_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00636\/abstract","author":"L Michel","year":"2015","unstructured":"Michel L, Touil H, Pikor NB, Gommerman JL, Prat A, Bar-Or A. B cells in the multiple sclerosis central nervous system: trafficking and contribution to CNS-compartmentalized inflammation. Front Immunol [Internet]. 2015. https:\/\/doi.org\/10.3389\/fimmu.2015.00636\/abstract.","journal-title":"Front Immunol [Internet]."},{"issue":"6","key":"737_CR15","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/S1474-4422(21)00063-6","volume":"20","author":"A Bar-Or","year":"2021","unstructured":"Bar-Or A, Li R. Cellular immunology of relapsing multiple sclerosis: interactions, checks, and balances. Lancet Neurol. 2021;20(6):470\u201383.","journal-title":"Lancet Neurol"},{"key":"737_CR16","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.62.6.865","author":"MS Freedman","year":"2005","unstructured":"Freedman MS, Thompson EJ, Deisenhammer F, Giovannoni G, Grimsley G, Keir G, et al. Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis: a consensus statement. Arch Neurol [Internet]. 2005. https:\/\/doi.org\/10.1001\/archneur.62.6.865.","journal-title":"Arch Neurol [Internet]."},{"issue":"12","key":"737_CR17","doi-asserted-by":"publisher","first-page":"3796","DOI":"10.3390\/ijms19123796","volume":"19","author":"P Schwenkenbecher","year":"2018","unstructured":"Schwenkenbecher P, Konen FF, Wurster U, Jendretzky KF, Gingele S, S\u00fchs KW, et al. The persisting significance of oligoclonal bands in the dawning era of kappa free light chains for the diagnosis of multiple sclerosis. Int J Mol Sci. 2018;19(12):3796.","journal-title":"Int J Mol Sci"},{"issue":"10","key":"737_CR18","doi-asserted-by":"publisher","first-page":"856","DOI":"10.3390\/diagnostics10100856","volume":"10","author":"D Ferraro","year":"2020","unstructured":"Ferraro D, Bedin R, Natali P, Franciotta D, Smolik K, Santangelo M, et al. Kappa index versus CSF oligoclonal bands in predicting multiple sclerosis and infectious\/inflammatory CNS disorders. Diagnostics. 2020;10(10):856.","journal-title":"Diagnostics"},{"key":"737_CR19","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.clineuro.2018.09.031","volume":"174","author":"M Vasilj","year":"2018","unstructured":"Vasilj M, Kes VB, Vrkic N, Vukasovic I. Relevance of KFLC quantification to differentiate clinically isolated syndrome from multiple sclerosis at clinical onset. Clin Neurol Neurosurg. 2018;174:220\u20139.","journal-title":"Clin Neurol Neurosurg"},{"issue":"8","key":"737_CR20","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1136\/jnnp-2012-304695","volume":"84","author":"R Dobson","year":"2013","unstructured":"Dobson R, Ramagopalan S, Davis A, Giovannoni G. Cerebrospinal fluid oligoclonal bands in multiple sclerosis and clinically isolated syndromes: a meta-analysis of prevalence, prognosis and effect of latitude. J Neurol Neurosurg Psychiatry. 2013;84(8):909\u201314.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"737_CR21","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/j.1600-0404.2010.01454.x","volume":"124","author":"N Sch\u00e4ffler","year":"2011","unstructured":"Sch\u00e4ffler N, K\u00f6pke S, Winkler L, Schippling S, Inglese M, Fischer K, et al. Accuracy of diagnostic tests in multiple sclerosis\u2014a systematic review: diagnostic tests in MS. Acta Neurol Scand. 2011;124(3):151\u201364.","journal-title":"Acta Neurol Scand"},{"issue":"11","key":"737_CR22","doi-asserted-by":"publisher","first-page":"3056","DOI":"10.3390\/cells10113056","volume":"10","author":"FF Konen","year":"2021","unstructured":"Konen FF, Schwenkenbecher P, Jendretzky KF, Gingele S, S\u00fchs KW, Tumani H, et al. The increasing role of kappa free light chains in the diagnosis of multiple sclerosis. Cells. 2021;10(11):3056.","journal-title":"Cells"},{"issue":"S2","key":"737_CR23","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s10072-017-3034-2","volume":"38","author":"M Gastaldi","year":"2017","unstructured":"Gastaldi M, Zardini E, Leante R, Ruggieri M, Costa G, Cocco E, et al. Cerebrospinal fluid analysis and the determination of oligoclonal bands. Neurol Sci. 2017;38(S2):217\u201324.","journal-title":"Neurol Sci"},{"issue":"3","key":"737_CR24","doi-asserted-by":"publisher","first-page":"e91","DOI":"10.1515\/cclm-2020-1037","volume":"59","author":"S Mariotto","year":"2021","unstructured":"Mariotto S, Ferraro D, Soldani F, Alberti D, Bedin R, Sola P, et al. Inter-center agreement in the interpretation of oligoclonal bands. Clin Chem Lab Med CCLM. 2021;59(3):e91\u20134.","journal-title":"Clin Chem Lab Med CCLM"},{"issue":"13_Part_2","key":"737_CR25","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1212\/01.wnl.0000280576.73609.c6","volume":"70","author":"M Tintor\u00e9","year":"2008","unstructured":"Tintor\u00e9 M, Rovira A, R\u00edo J, Tur C, Pelayo R, Nos C, et al. Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis? Neurology. 2008;70(13_Part_2):1079\u201383.","journal-title":"Neurology"},{"issue":"8","key":"737_CR26","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1177\/1352458514568827","volume":"21","author":"J Kuhle","year":"2015","unstructured":"Kuhle J, Disanto G, Dobson R, Adiutori R, Bianchi L, Topping J, et al. Conversion from clinically isolated syndrome to multiple sclerosis: a large multicentre study. Mult Scler J. 2015;21(8):1013\u201324.","journal-title":"Mult Scler J"},{"issue":"4","key":"737_CR27","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1093\/brain\/awy006","volume":"141","author":"G Arrambide","year":"2018","unstructured":"Arrambide G, Tintore M, Espejo C, Auger C, Castillo M, R\u00edo J, et al. The value of oligoclonal bands in the multiple sclerosis diagnostic criteria. Brain. 2018;141(4):1075\u201384.","journal-title":"Brain"},{"issue":"4","key":"737_CR28","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1093\/brain\/awy021","volume":"141","author":"C Matute-Blanch","year":"2018","unstructured":"Matute-Blanch C, Villar LM, \u00c1lvarez-Cerme\u00f1o JC, Rejdak K, Evdoshenko E, Makshakov G, et al. Neurofilament light chain and oligoclonal bands are prognostic biomarkers in radiologically isolated syndrome. Brain. 2018;141(4):1085\u201393.","journal-title":"Brain"},{"issue":"1","key":"737_CR29","first-page":"205521731983666","volume":"5","author":"N Makhani","year":"2019","unstructured":"Makhani N, Lebrun C, Siva A, Narula S, Wassmer E, Brassat D, et al. Oligoclonal bands increase the specificity of MRI criteria to predict multiple sclerosis in children with radiologically isolated syndrome. Mult Scler J Exp Transl Clin. 2019;5(1):2055217319836664.","journal-title":"Mult Scler J Exp Transl Clin"},{"key":"737_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2023.104948","volume":"79","author":"D Y\u0131lmaz","year":"2023","unstructured":"Y\u0131lmaz D, Teber S, G\u00fcltutan P, Y\u0131ld\u0131r\u0131m M, Bekta\u015f \u00d6, Alik\u0131l\u0131\u00e7 D, et al. A multicenter study of radiologically isolated syndrome in children and adolescents: can we predict the course? Mult Scler Relat Disord. 2023;79: 104948.","journal-title":"Mult Scler Relat Disord"},{"issue":"5","key":"737_CR31","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1002\/ana.25237","volume":"83","author":"A Huss","year":"2018","unstructured":"Huss A, Abdelhak A, Halbgebauer S, Mayer B, Senel M, Otto M, et al. Intrathecal immunoglobulin M production: a promising high-risk marker in clinically isolated syndrome patients. Ann Neurol. 2018;83(5):1032\u20136.","journal-title":"Ann Neurol"},{"issue":"5","key":"737_CR32","doi-asserted-by":"publisher","first-page":"e1047","DOI":"10.1212\/NXI.0000000000001047","volume":"8","author":"E Monreal","year":"2021","unstructured":"Monreal E, Sainz De La Maza S, Costa-Frossard L, Walo-Delgado P, Zamora J, Fern\u00e1ndez-Velasco JI, et al. Predicting aggressive multiple sclerosis with intrathecal IgM synthesis among patients with a clinically isolated syndrome. Neurol Neuroimmunol Neuroinflamm. 2021;8(5):e1047.","journal-title":"Neurol Neuroimmunol Neuroinflamm."},{"issue":"3","key":"737_CR33","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1002\/ana.26137","volume":"90","author":"J Oechtering","year":"2021","unstructured":"Oechtering J, Schaedelin S, Benkert P, M\u00fcller S, Achtnichts L, Vehoff J, et al. Intrathecal immunoglobulin M synthesis is an independent biomarker for higher disease activity and severity in multiple sclerosis. Ann Neurol. 2021;90(3):477\u201389.","journal-title":"Ann Neurol"},{"issue":"4","key":"737_CR34","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1111\/j.1600-0404.1991.tb04689.x","volume":"83","author":"F Lolli","year":"1991","unstructured":"Lolli F, Siracusa G, Amato MP, Fratiglioni L, Pozzo GD, Galli E, et al. Intrathecal synthesis of free immunoglobulin light chains and IgM in initial multiple sclerosis. Acta Neurol Scand. 1991;83(4):239\u201343.","journal-title":"Acta Neurol Scand"},{"key":"737_CR35","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.cca.2019.07.027","volume":"497","author":"H Reiber","year":"2019","unstructured":"Reiber H, Zeman D, Ku\u0161nierov\u00e1 P, Mundwiler E, Bernasconi L. Diagnostic relevance of free light chains in cerebrospinal fluid\u2014the hyperbolic reference range for reliable data interpretation in quotient diagrams. Clin Chim Acta. 2019;497:153\u201362.","journal-title":"Clin Chim Acta"},{"issue":"4","key":"737_CR36","doi-asserted-by":"publisher","first-page":"475","DOI":"10.3390\/brainsci12040475","volume":"12","author":"FF Konen","year":"2022","unstructured":"Konen FF, Schwenkenbecher P, Jendretzky KF, Gingele S, Witte T, S\u00fchs KW, et al. Kappa free light chains in cerebrospinal fluid in inflammatory and non-inflammatory neurological diseases. Brain Sci. 2022;12(4):475.","journal-title":"Brain Sci"},{"issue":"3","key":"737_CR37","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1111\/jnc.15500","volume":"159","author":"I Rosenstein","year":"2021","unstructured":"Rosenstein I, Rasch S, Axelsson M, Novakova L, Blennow K, Zetterberg H, et al. Kappa free light chain index as a diagnostic biomarker in multiple sclerosis: a real-world investigation. J Neurochem. 2021;159(3):618\u201328.","journal-title":"J Neurochem"},{"issue":"1","key":"737_CR38","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000200049","volume":"10","author":"M Levraut","year":"2023","unstructured":"Levraut M, Laurent-Chabalier S, Ayrignac X, Bigaut K, Rival M, Squalli S, et al. Kappa free light chain biomarkers are efficient for the diagnosis of multiple sclerosis: a large multicenter cohort study. Neurol Neuroimmunol Neuroinflamm. 2023;10(1): e200049.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"4","key":"737_CR39","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1177\/1352458515594044","volume":"22","author":"S Presslauer","year":"2016","unstructured":"Presslauer S, Milosavljevic D, Huebl W, Aboulenein-Djamshidian F, Krugluger W, Deisenhammer F, et al. Validation of kappa free light chains as a diagnostic biomarker in multiple sclerosis and clinically isolated syndrome: a multicenter study. Mult Scler J. 2016;22(4):502\u201310.","journal-title":"Mult Scler J"},{"issue":"2","key":"737_CR40","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1515\/cclm-2018-0400","volume":"57","author":"M Christiansen","year":"2018","unstructured":"Christiansen M, Gjelstrup MC, Stilund M, Christensen T, Petersen T, Jon MH. Cerebrospinal fluid free kappa light chains and kappa index perform equal to oligoclonal bands in the diagnosis of multiple sclerosis. Clin Chem Lab Med CCLM. 2018;57(2):210\u201320.","journal-title":"Clin Chem Lab Med CCLM"},{"key":"737_CR41","doi-asserted-by":"publisher","first-page":"641","DOI":"10.3389\/fimmu.2019.00641","volume":"10","author":"M Senel","year":"2019","unstructured":"Senel M, Mojib-Yezdani F, Braisch U, Bachhuber F, Lewerenz J, Ludolph AC, et al. CSF free light chains as a marker of intrathecal immunoglobulin synthesis in multiple sclerosis: a blood-CSF barrier related evaluation in a large cohort. Front Immunol. 2019;10:641.","journal-title":"Front Immunol"},{"issue":"1","key":"737_CR42","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.autrev.2018.07.010","volume":"18","author":"P Men\u00e9ndez-Valladares","year":"2019","unstructured":"Men\u00e9ndez-Valladares P, Garc\u00eda-S\u00e1nchez MI, Adorna Mart\u00ednez M, Garc\u00eda De Veas Silva JL, Bermudo Guitarte C, Izquierdo Ayuso G. Validation and meta-analysis of kappa index biomarker in multiple sclerosis diagnosis. Autoimmun Rev. 2019;18(1):43\u20139.","journal-title":"Autoimmun Rev"},{"issue":"4","key":"737_CR43","doi-asserted-by":"publisher","first-page":"446","DOI":"10.3390\/jcm8040446","volume":"8","author":"I Crespi","year":"2019","unstructured":"Crespi I, Vecchio D, Serino R, Saliva E, Virgilio E, Sulas MG, et al. K index is a reliable marker of intrathecal synthesis, and an alternative to IgG index in multiple sclerosis diagnostic work-up. J Clin Med. 2019;8(4):446.","journal-title":"J Clin Med"},{"key":"737_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2019.577108","volume":"339","author":"L Gaetani","year":"2020","unstructured":"Gaetani L, Di Carlo M, Brachelente G, Valletta F, Eusebi P, Mancini A, et al. Cerebrospinal fluid free light chains compared to oligoclonal bands as biomarkers in multiple sclerosis. J Neuroimmunol. 2020;339: 577108.","journal-title":"J Neuroimmunol"},{"key":"737_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2019.577122","volume":"339","author":"P Cavalla","year":"2020","unstructured":"Cavalla P, Caropreso P, Limoncelli S, Bosa C, Pasanisi MB, Schillaci V, et al. Kappa free light chains index in the differential diagnosis of multiple sclerosis from neuromyelitis optica spectrum disorders and other immune-mediated central nervous system disorders. J Neuroimmunol. 2020;339: 577122.","journal-title":"J Neuroimmunol"},{"issue":"8","key":"737_CR46","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1177\/1352458519845844","volume":"26","author":"C Leurs","year":"2020","unstructured":"Leurs C, Twaalfhoven H, Lissenberg-Witte B, Van Pesch V, Dujmovic I, Drulovic J, et al. Kappa free light chains is a valid tool in the diagnostics of MS: a large multicenter study. Mult Scler J. 2020;26(8):912\u201323.","journal-title":"Mult Scler J"},{"issue":"3","key":"737_CR47","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1111\/ene.14121","volume":"27","author":"D Ferraro","year":"2020","unstructured":"Ferraro D, Trovati A, Bedin R, Natali P, Franciotta D, Santangelo M, et al. Cerebrospinal fluid kappa and lambda free light chains in oligoclonal band-negative patients with suspected multiple sclerosis. Eur J Neurol. 2020;27(3):461\u20137.","journal-title":"Eur J Neurol"},{"key":"737_CR48","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.864133","volume":"13","author":"M Levraut","year":"2022","unstructured":"Levraut M, Landes C, Mondot L, Cohen M, Bresch S, Brglez V, et al. Kappa free light chains, soluble interleukin-2 receptor, and interleukin-6 help explore patients presenting with brain white matter hyperintensities. Front Immunol. 2022;13: 864133.","journal-title":"Front Immunol"},{"issue":"9","key":"737_CR49","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1177\/13524585211064121","volume":"28","author":"G Bernardi","year":"2022","unstructured":"Bernardi G, Biagioli T, Malpassi P, De Michele T, Vecchio D, Repice AM, et al. The contribute of cerebrospinal fluid free light-chain assay in the diagnosis of multiple sclerosis and other neurological diseases in an Italian multicenter study. Mult Scler J t. 2022;28(9):1364\u201372.","journal-title":"Mult Scler J t"},{"key":"737_CR50","doi-asserted-by":"publisher","first-page":"1288169","DOI":"10.3389\/fimmu.2023.1288169","volume":"14","author":"E Monreal","year":"2023","unstructured":"Monreal E, Fern\u00e1ndez-Velasco JI, Garc\u00eda-Soid\u00e1n A, Sainz De La Maza S, Espi\u00f1o M, Villarrubia N, et al. Establishing the best combination of the kappa free light chain index and oligoclonal bands for an accurate diagnosis of multiple sclerosis. Front Immunol. 2023;14:1288169.","journal-title":"Front Immunol"},{"key":"737_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2023.105125","volume":"81","author":"K Zondra Revendova","year":"2024","unstructured":"Zondra Revendova K, Svub K, Bunganic R, Pelisek O, Volny O, Ganesh A, et al. A comparison of measles-rubella-zoster reaction, oligoclonal IgG bands, oligoclonal kappa free light chains and kappa index in multiple sclerosis. Mult Scler Relat Disord. 2024;81: 105125.","journal-title":"Mult Scler Relat Disord"},{"issue":"2","key":"737_CR52","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1177\/13524585221134213","volume":"29","author":"H Hegen","year":"2023","unstructured":"Hegen H, Walde J, Berek K, Arrambide G, Gnanapavan S, Kaplan B, et al. Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis: a systematic review and meta-analysis. Mult Scler J. 2023;29(2):169\u201381.","journal-title":"Mult Scler J"},{"issue":"3","key":"737_CR53","doi-asserted-by":"publisher","first-page":"616","DOI":"10.3390\/cells10030616","volume":"10","author":"MJ Hannich","year":"2021","unstructured":"Hannich MJ, Dressel A, Budde K, Petersmann A, Nauck M, S\u00fc\u00dfe M. Kappa free light chains in the context of blood contamination, and other IgA- and IgM-related cerebrospinal fluid disease pattern. Cells. 2021;10(3):616.","journal-title":"Cells"},{"key":"737_CR54","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.827738","volume":"13","author":"J Castillo-Villalba","year":"2022","unstructured":"Castillo-Villalba J, Gil-Perot\u00edn S, Gasque-Rubio R, Cubas-Nu\u00f1ez L, Carratal\u00e0-Bosc\u00e0 S, Alcal\u00e1 C, et al. High levels of cerebrospinal fluid kappa free light chains relate to IgM intrathecal synthesis and might have prognostic implications in relapsing multiple sclerosis. Front Immunol. 2022;13: 827738.","journal-title":"Front Immunol"},{"issue":"1","key":"737_CR55","doi-asserted-by":"publisher","first-page":"90","DOI":"10.3390\/biom15010090","volume":"15","author":"K Smolik","year":"2025","unstructured":"Smolik K, Bedin R, Natali P, Cardi M, Franciotta D, Simone AM, et al. Elevated kappa index in the absence of cerebrospinal fluid IgG oligoclonal bands: contribution of intrathecal IgM and IgA synthesis. Biomolecules. 2025;15(1):90.","journal-title":"Biomolecules"},{"key":"737_CR56","doi-asserted-by":"publisher","first-page":"1327947","DOI":"10.3389\/fimmu.2023.1327947","volume":"14","author":"H Hegen","year":"2023","unstructured":"Hegen H, Berek K, Cavalla P, Christiansen M, Emer\u0161i\u010d A, Di Filippo M, et al. Diagnostic value of kappa free light chain index in patients with primary progressive multiple sclerosis\u2014a multicentre study. Front Immunol. 2023;14:1327947.","journal-title":"Front Immunol"},{"issue":"11\u201312","key":"737_CR57","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1177\/13524585241274034","volume":"30","author":"A Sarthou","year":"2024","unstructured":"Sarthou A, Chr\u00e9tien P, Giorgi L, Chiron A, Leroy C, Horellou P, et al. The kappa free light chains index is an accurate diagnostic biomarker for paediatric multiple sclerosis. Mult Scler J. 2024;30(11\u201312):1436\u201344.","journal-title":"Mult Scler J"},{"issue":"6","key":"737_CR58","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000200156","volume":"10","author":"M Levraut","year":"2023","unstructured":"Levraut M, Gavoille A, Landes-Chateau C, Cohen M, Bresch S, Seitz-Polski B, et al. Kappa free light chain index predicts disease course in clinically and radiologically isolated syndromes. Neurol Neuroimmunol Neuroinflamm. 2023;10(6): e200156.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"1","key":"737_CR59","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s00415-024-12826-y","volume":"272","author":"D Vecchio","year":"2025","unstructured":"Vecchio D, Puricelli C, Virgilio E, Passarelli F, Guida S, Naldi P, et al. Kappa index for multiple sclerosis diagnosis: an accurate biomarker of intrathecal synthesis. J Neurol. 2025;272(1):30.","journal-title":"J Neurol"},{"key":"737_CR60","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.msard.2019.02.001","volume":"30","author":"D Vecchio","year":"2019","unstructured":"Vecchio D, Crespi I, Virgilio E, Naldi P, Campisi MP, Serino R, et al. Kappa free light chains could predict early disease course in multiple sclerosis. Mult Scler Relat Disord. 2019;30:81\u20134.","journal-title":"Mult Scler Relat Disord"},{"issue":"4","key":"737_CR61","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000001005","volume":"8","author":"K Berek","year":"2021","unstructured":"Berek K, Bsteh G, Auer M, Di Pauli F, Grams A, Milosavljevic D, et al. Kappa-free light chains in CSF predict early multiple sclerosis disease activity. Neurol Neuroimmunol Neuroinflamm. 2021;8(4): e1005.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"11","key":"737_CR62","doi-asserted-by":"publisher","first-page":"3931","DOI":"10.1093\/brain\/awac220","volume":"145","author":"G Arrambide","year":"2022","unstructured":"Arrambide G, Espejo C, Carbonell-Mirabent P, Dieli-Crimi R, Rodr\u00edguez-Barranco M, Castillo M, et al. The kappa free light chain index and oligoclonal bands have a similar role in the McDonald criteria. Brain. 2022;145(11):3931\u201342.","journal-title":"Brain"},{"key":"737_CR63","doi-asserted-by":"publisher","first-page":"104573","DOI":"10.1016\/j.ebiom.2023.104573","volume":"91","author":"H Hegen","year":"2023","unstructured":"Hegen H, Berek K, Bsteh G, Auer M, Altmann P, Di Pauli F, et al. Kappa free light chain and neurofilament light independently predict early multiple sclerosis disease activity\u2014a cohort study. EBioMedicine. 2023;91:104573.","journal-title":"EBioMedicine"},{"issue":"10","key":"737_CR64","doi-asserted-by":"publisher","first-page":"4800","DOI":"10.1007\/s00415-023-11817-9","volume":"270","author":"I Rosenstein","year":"2023","unstructured":"Rosenstein I, Axelsson M, Novakova L, Malmestr\u00f6m C, Blennow K, Zetterberg H, et al. Intrathecal kappa free light chain synthesis is associated with worse prognosis in relapsing\u2013remitting multiple sclerosis. J Neurol. 2023;270(10):4800\u201311.","journal-title":"J Neurol"},{"issue":"6","key":"737_CR65","doi-asserted-by":"publisher","first-page":"324","DOI":"10.3390\/brainsci10060324","volume":"10","author":"M Gudowska-Sawczuk","year":"2020","unstructured":"Gudowska-Sawczuk M, Tarasiuk J, Ku\u0142akowska A, Kochanowicz J, Mroczko B. Kappa free light chains and IgG combined in a novel algorithm for the detection of multiple sclerosis. Brain Sci. 2020;10(6):324.","journal-title":"Brain Sci"},{"issue":"9","key":"737_CR66","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1111\/ene.13667","volume":"25","author":"M S\u00fc\u00dfe","year":"2018","unstructured":"S\u00fc\u00dfe M, Hannich M, Petersmann A, Zylla S, Pietzner M, Nauck M, et al. Kappa free light chains in cerebrospinal fluid to identify patients with oligoclonal bands. Eur J Neurol. 2018;25(9):1134\u20139.","journal-title":"Eur J Neurol"},{"issue":"5","key":"737_CR67","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1136\/jcp-2022-208354","volume":"76","author":"MA Abid","year":"2023","unstructured":"Abid MA, Ahmed S, Muneer S, Khan S, De Oliveira MHS, Kausar R, et al. Evaluation of CSF kappa free light chains for the diagnosis of multiple sclerosis (MS): a comparison with oligoclonal bands (OCB) detection via isoelectric focusing (IEF) coupled with immunoblotting. J Clin Pathol. 2023;76(5):353\u20136.","journal-title":"J Clin Pathol"},{"key":"737_CR68","doi-asserted-by":"publisher","first-page":"676527","DOI":"10.3389\/fneur.2021.676527","volume":"12","author":"CT Sanz Diaz","year":"2021","unstructured":"Sanz Diaz CT, De Las Heras Fl\u00f3rez S, Carretero Perez M, Hern\u00e1ndez P\u00e9rez M\u00c1, Mart\u00edn Garc\u00eda V. Evaluation of kappa index as a tool in the diagnosis of multiple sclerosis: implementation in routine screening procedure. Front Neurol. 2021;12:676527.","journal-title":"Front Neurol"},{"issue":"9","key":"737_CR69","doi-asserted-by":"publisher","first-page":"2865","DOI":"10.1111\/ene.15897","volume":"30","author":"R Deschamps","year":"2023","unstructured":"Deschamps R, Shor N, Papeix C, Boudot de la Motte M, Bensa C, Marignier R, et al. Relevance of kappa free light chains index in patients with aquaporin-4 or myelin-oligodendrocyte-glycoprotein antibodies. Eur J Neurol. 2023;30(9):2865\u20139.","journal-title":"Eur J Neurol"},{"issue":"10","key":"737_CR70","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1515\/cclm-2023-1018","volume":"62","author":"L Hagberg","year":"2024","unstructured":"Hagberg L, Rosenstein I, Lycke J, Zetterberg H, Yilmaz A, Ed\u00e9n A, et al. IgG and kappa free light chain CSF\/serum indices: evaluating intrathecal immunoglobulin production in HIV infection in comparison with multiple sclerosis. Clin Chem Lab Med CCLM. 2024;62(10):2024\u20139.","journal-title":"Clin Chem Lab Med CCLM"},{"issue":"1","key":"737_CR71","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1515\/cclm-2023-1468","volume":"63","author":"MJ Hannich","year":"2025","unstructured":"Hannich MJ, Konen FF, Gag K, Alkhayer A, T\u00fcrker SN, Budde K, et al. Implications of monoclonal gammopathy and isoelectric focusing pattern 5 on the free light chain kappa diagnostics in cerebrospinal fluid. Clin Chem Lab Med CCLM. 2025;63(1):147\u201353.","journal-title":"Clin Chem Lab Med CCLM"},{"issue":"5","key":"737_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2025.103765","volume":"24","author":"FF Konen","year":"2025","unstructured":"Konen FF, Wurster U, Schwenkenbecher P, Gerritzen A, Gro\u00df CC, Eichhorn P, et al. Oligoclonal bands and kappa free light chains: competing parameters or complementary biomarkers? Autoimmun Rev. 2025;24(5): 103765.","journal-title":"Autoimmun Rev"},{"issue":"6","key":"737_CR73","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1093\/ajcp\/aqx037","volume":"147","author":"AS Messiaen","year":"2017","unstructured":"Messiaen AS, De Sloovere MMW, Claus PE, Vercammen M, Van Hoovels L, Heylen O, et al. Performance evaluation of serum free light chain analysis. Am J Clin Pathol. 2017;147(6):611\u201322.","journal-title":"Am J Clin Pathol"},{"issue":"5","key":"737_CR74","doi-asserted-by":"publisher","first-page":"677","DOI":"10.3390\/biom12050677","volume":"12","author":"P Natali","year":"2022","unstructured":"Natali P, Bedin R, Bernardi G, Corsini E, Cocco E, Schirru L, et al. Inter-laboratory concordance of cerebrospinal fluid and serum kappa free light chain measurements. Biomolecules. 2022;12(5):677.","journal-title":"Biomolecules"},{"key":"737_CR75","doi-asserted-by":"publisher","first-page":"1385231","DOI":"10.3389\/fimmu.2024.1385231","volume":"15","author":"C Dekeyser","year":"2024","unstructured":"Dekeyser C, De Kesel P, Cambron M, Vanopdenbosch L, Van Hijfte L, Vercammen M, et al. Inter-assay diagnostic accuracy of cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis. Front Immunol. 2024;15:1385231.","journal-title":"Front Immunol"},{"key":"737_CR76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/2303857","volume":"2016","author":"G Passerini","year":"2016","unstructured":"Passerini G, Dalla Costa G, Sangalli F, Moiola L, Colombo B, Locatelli M, et al. Free light chains and intrathecal B cells activity in multiple sclerosis: a prospective study and meta-analysis. Mult Scler Int. 2016;2016:1\u20139.","journal-title":"Mult Scler Int"},{"issue":"7","key":"737_CR77","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1515\/cclm-2017-0901","volume":"56","author":"KM Gurtner","year":"2018","unstructured":"Gurtner KM, Shosha E, Bryant SC, Andreguetto BD, Murray DL, Pittock SJ, et al. CSF free light chain identification of demyelinating disease: comparison with oligoclonal banding and other CSF indexes. Clin Chem Lab Med CCLM. 2018;56(7):1071\u201380.","journal-title":"Clin Chem Lab Med CCLM"},{"issue":"4","key":"737_CR78","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1515\/cclm-2017-0285","volume":"56","author":"E Valencia-Vera","year":"2018","unstructured":"Valencia-Vera E, Martinez-Escribano Garcia-Ripoll A, Enguix A, Abalos-Garcia C, Segovia-Cuevas MJ. Application of \u03ba free light chains in cerebrospinal fluid as a biomarker in multiple sclerosis diagnosis: development of a diagnosis algorithm. Clin Chem Lab Med CCLM. 2018;56(4):609\u201313.","journal-title":"Clin Chem Lab Med CCLM"},{"issue":"4","key":"737_CR79","doi-asserted-by":"publisher","first-page":"842","DOI":"10.3390\/cells9040842","volume":"9","author":"FF Konen","year":"2020","unstructured":"Konen FF, Wurster U, Witte T, Jendretzky KF, Gingele S, Tumani H, et al. The impact of immunomodulatory treatment on kappa free light chains as biomarker in neuroinflammation. Cells. 2020;9(4):842.","journal-title":"Cells"},{"issue":"3","key":"737_CR80","doi-asserted-by":"publisher","first-page":"720","DOI":"10.3390\/diagnostics12030720","volume":"12","author":"M S\u00fc\u00dfe","year":"2022","unstructured":"S\u00fc\u00dfe M, Konen FF, Schwenkenbecher P, Budde K, Nauck M, Grothe M, et al. Decreased intrathecal concentrations of free light chains kappa in multiple sclerosis patients taking very high effective disease-modifying treatment. Diagnostics. 2022;12(3):720.","journal-title":"Diagnostics"},{"key":"737_CR81","doi-asserted-by":"publisher","first-page":"117957352110421","DOI":"10.1177\/11795735211042166","volume":"13","author":"FF Konen","year":"2021","unstructured":"Konen FF, Schwenkenbecher P, Wurster U, Jendretzky KF, M\u00f6hn N, Gingele S, et al. The influence of renal function impairment on kappa free light chains in cerebrospinal fluid. J Cent Nerv Syst Dis. 2021;13:11795735211042166.","journal-title":"J Cent Nerv Syst Dis"},{"issue":"2","key":"737_CR82","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.msard.2013.08.005","volume":"3","author":"AD Rae-Grant","year":"2014","unstructured":"Rae-Grant AD, Wong C, Bernatowicz R, Fox RJ. Observations on the brain vasculature in multiple sclerosis: a historical perspective. Mult Scler Relat Disord. 2014;3(2):156\u201362.","journal-title":"Mult Scler Relat Disord"},{"issue":"7","key":"737_CR83","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1093\/brain\/awy151","volume":"141","author":"J Machado-Santos","year":"2018","unstructured":"Machado-Santos J, Saji E, Tr\u00f6scher AR, Paunovic M, Liblau R, Gabriely G, et al. The compartmentalized inflammatory response in the multiple sclerosis brain is composed of tissue-resident CD8+ T lymphocytes and B cells. Brain. 2018;141(7):2066\u201382.","journal-title":"Brain"},{"issue":"4","key":"737_CR84","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1002\/ana.20016","volume":"55","author":"MH Barnett","year":"2004","unstructured":"Barnett MH, Prineas JW. Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion. Ann Neurol. 2004;55(4):458\u201368.","journal-title":"Ann Neurol"},{"issue":"3","key":"737_CR85","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1097\/WCO.0000000000000205","volume":"28","author":"SK Yadav","year":"2015","unstructured":"Yadav SK, Mindur JE, Ito K, Dhib-Jalbut S. Advances in the immunopathogenesis of multiple sclerosis. Curr Opin Neurol. 2015;28(3):206\u201319.","journal-title":"Curr Opin Neurol"},{"issue":"4","key":"737_CR86","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1016\/j.neuroimage.2007.10.037","volume":"39","author":"KE Hammond","year":"2008","unstructured":"Hammond KE, Lupo JM, Xu D, Metcalf M, Kelley DAC, Pelletier D, et al. Development of a robust method for generating 7.0 T multichannel phase images of the brain with application to normal volunteers and patients with neurological diseases. Neuroimage. 2008;39(4):1682\u201392.","journal-title":"Neuroimage"},{"issue":"22","key":"737_CR87","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1212\/01.wnl.0000313377.49555.2e","volume":"70","author":"EC Tallantyre","year":"2008","unstructured":"Tallantyre EC, Brookes MJ, Dixon JE, Morgan PS, Evangelou N, Morris PG. Demonstrating the perivascular distribution of MS lesions in vivo with 7-tesla MRI. Neurology. 2008;70(22):2076\u20138.","journal-title":"Neurology"},{"issue":"11","key":"737_CR88","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1177\/1352458514525868","volume":"20","author":"P Sati","year":"2014","unstructured":"Sati P, Thomasson D, Li N, Pham D, Biassou N, Reich D, et al. Rapid, high-resolution, whole-brain, susceptibility-based MRI of multiple sclerosis. Mult Scler J. 2014;20(11):1464\u201370.","journal-title":"Mult Scler J"},{"issue":"3","key":"737_CR89","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1002\/acn3.51986","volume":"11","author":"C Landes-Chateau","year":"2024","unstructured":"Landes-Chateau C, Levraut M, Okuda DT, Themelin A, Cohen M, Kantarci OH, et al. The diagnostic value of the central vein sign in radiologically isolated syndrome. Ann Clin Transl Neurol. 2024;11(3):662\u201372.","journal-title":"Ann Clin Transl Neurol"},{"issue":"2","key":"737_CR90","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/ana.25146","volume":"83","author":"P Maggi","year":"2018","unstructured":"Maggi P, Absinta M, Grammatico M, Vuolo L, Emmi G, Carlucci G, et al. Central vein sign differentiates Multiple Sclerosis from central nervous system inflammatory vasculopathies. Ann Neurol. 2018;83(2):283\u201394.","journal-title":"Ann Neurol"},{"key":"737_CR91","doi-asserted-by":"crossref","unstructured":"Manning AR, Letchuman V, Martin ML, Gombos E, Roberts-Fitzgerald T, Cao Q, et al. Multicenter automated central vein sign detection performs as well as manual assessment for the diagnosis of multiple sclerosis. AJNR Am J Neuroradiol. 2024;46(3):620\u20136.","DOI":"10.3174\/ajnr.A8510"},{"key":"737_CR92","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2021.102834","volume":"32","author":"D Ontaneda","year":"2021","unstructured":"Ontaneda D, Sati P, Raza P, Kilbane M, Gombos E, Alvarez E, et al. Central vein sign: a diagnostic biomarker in multiple sclerosis (CAVS-MS) study protocol for a prospective multicenter trial. NeuroImage Clin. 2021;32: 102834.","journal-title":"NeuroImage Clin"},{"key":"737_CR93","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.mri.2022.07.013","volume":"93","author":"U Jensen-Kondering","year":"2022","unstructured":"Jensen-Kondering U, Larsen N, Huhndorf M, Jansen O, L\u00fcddecke R, St\u00fcrner K, et al. Central vein sign in patients with inflammatory lesion of the upper cervical spinal cord on susceptibility weighted imaging at 3 tesla. Preliminary results. Magn Reson Imaging. 2022;93:11\u20134.","journal-title":"Magn Reson Imaging"},{"issue":"1","key":"737_CR94","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1148\/radiology.204.1.9205259","volume":"204","author":"JR Reichenbach","year":"1997","unstructured":"Reichenbach JR, Venkatesan R, Schillinger DJ, Kido DK, Haacke EM. Small vessels in the human brain: MR venography with deoxyhemoglobin as an intrinsic contrast agent. Radiology. 1997;204(1):272\u20137.","journal-title":"Radiology"},{"issue":"3","key":"737_CR95","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1002\/mrm.20198","volume":"52","author":"EM Haacke","year":"2004","unstructured":"Haacke EM, Xu Y, Cheng YN, Reichenbach JR. Susceptibility weighted imaging (SWI). Magn Reson Med. 2004;52(3):612\u20138.","journal-title":"Magn Reson Med"},{"issue":"12","key":"737_CR96","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1038\/nrneurol.2016.166","volume":"12","author":"P Sati","year":"2016","unstructured":"On Behalf of the NAIMS Cooperative, Sati P, Oh J, Constable RT, Evangelou N, Guttmann CRG, et al. The central vein sign and its clinical evaluation for the diagnosis of multiple sclerosis: a consensus statement from the North American Imaging in Multiple Sclerosis Cooperative. Nat Rev Neurol. 2016;12(12):714\u201322.","journal-title":"Nat Rev Neurol"},{"issue":"3","key":"737_CR97","doi-asserted-by":"publisher","first-page":"456","DOI":"10.3174\/ajnr.A6437","volume":"41","author":"MI Gait\u00e1n","year":"2020","unstructured":"Gait\u00e1n MI, Ya\u00f1ez P, Paday Formenti ME, Calandri I, Figueiredo E, Sati P, et al. SWAN-venule: an optimized MRI technique to detect the central vein sign in MS plaques. Am J Neuroradiol. 2020;41(3):456\u201360.","journal-title":"Am J Neuroradiol"},{"issue":"12","key":"737_CR98","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1001\/jamaneurol.2019.2478","volume":"76","author":"T Sinnecker","year":"2019","unstructured":"Sinnecker T, Clarke MA, Meier D, Enzinger C, Calabrese M, De Stefano N, et al. Evaluation of the central vein sign as a diagnostic imaging biomarker in multiple sclerosis. JAMA Neurol. 2019;76(12):1446.","journal-title":"JAMA Neurol"},{"issue":"1","key":"737_CR99","doi-asserted-by":"publisher","first-page":"76","DOI":"10.3174\/ajnr.A8083","volume":"45","author":"L Okromelidze","year":"2024","unstructured":"Okromelidze L, Patel V, Singh RB, Lopez Chiriboga AS, Tao S, Zhou X, et al. Central vein sign in multiple sclerosis: a comparison study of the diagnostic performance of 3T versus 7T MRI. Am J Neuroradiol. 2024;45(1):76\u201381.","journal-title":"Am J Neuroradiol"},{"issue":"9","key":"737_CR100","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1097\/RLI.0b013e3181b4c144","volume":"44","author":"EC Tallantyre","year":"2009","unstructured":"Tallantyre EC, Morgan PS, Dixon JE, Al-Radaideh A, Brookes MJ, Evangelou N, et al. A comparison of 3T and 7T in the detection of small parenchymal veins within MS lesions. Investig Radiol. 2009;44(9):491\u20134.","journal-title":"Investig Radiol."},{"issue":"7","key":"737_CR101","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1007\/s00330-013-2791-4","volume":"23","author":"T Kau","year":"2013","unstructured":"Kau T, Taschwer M, Deutschmann H, Sch\u00f6nfelder M, Weber JR, Hausegger KA. The \u201ccentral vein sign\u201d: is there a place for susceptibility weighted imaging in possible multiple sclerosis? Eur Radiol. 2013;23(7):1956\u201362.","journal-title":"Eur Radiol"},{"issue":"5","key":"737_CR102","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.ejrad.2011.09.023","volume":"82","author":"JE Dixon","year":"2013","unstructured":"Dixon JE, Simpson A, Mistry N, Evangelou N, Morris PG. Optimisation of T 2 * -weighted MRI for the detection of small veins in multiple sclerosis at 3 T and 7 T. Eur J Radiol. 2013;82(5):719\u201327.","journal-title":"Eur J Radiol"},{"issue":"2","key":"737_CR103","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1002\/acn3.273","volume":"3","author":"AJ Solomon","year":"2016","unstructured":"Solomon AJ, Schindler MK, Howard DB, Watts R, Sati P, Nickerson JP, et al. \u201cCentral vessel sign\u201d on 3T FLAIR * MRI for the differentiation of multiple sclerosis from migraine. Ann Clin Transl Neurol. 2016;3(2):82\u20137.","journal-title":"Ann Clin Transl Neurol"},{"issue":"10","key":"737_CR104","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1177\/1352458515616700","volume":"22","author":"N Mistry","year":"2016","unstructured":"Mistry N, Abdel-Fahim R, Samaraweera A, Mougin O, Tallantyre E, Tench C, et al. Imaging central veins in brain lesions with 3-T T2*-weighted magnetic resonance imaging differentiates multiple sclerosis from microangiopathic brain lesions. Mult Scler J. 2016;22(10):1289\u201396.","journal-title":"Mult Scler J"},{"issue":"10","key":"737_CR105","doi-asserted-by":"publisher","first-page":"4257","DOI":"10.1007\/s00330-017-4822-z","volume":"27","author":"T Campion","year":"2017","unstructured":"Campion T, Smith RJP, Altmann DR, Brito GC, Turner BP, Evanson J, et al. FLAIR* to visualize veins in white matter lesions: a new tool for the diagnosis of multiple sclerosis? Eur Radiol. 2017;27(10):4257\u201363.","journal-title":"Eur Radiol"},{"issue":"2","key":"737_CR106","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1001\/jamaneurol.2023.4737","volume":"81","author":"A Cagol","year":"2024","unstructured":"Cagol A, Cortese R, Barakovic M, Schaedelin S, Ruberte E, Absinta M, et al. Diagnostic performance of cortical lesions and the central vein sign in multiple sclerosis. JAMA Neurol. 2024;81(2):143.","journal-title":"JAMA Neurol"},{"issue":"11","key":"737_CR107","doi-asserted-by":"publisher","first-page":"3031","DOI":"10.1002\/acn3.52208","volume":"11","author":"M Margoni","year":"2024","unstructured":"Margoni M, Preziosa P, Pagani E, Storelli L, Gueye M, Moiola L, et al. Assessment of central vein sign and paramagnetic rim lesions in pediatric multiple sclerosis. Ann Clin Transl Neurol. 2024;11(11):3031\u20136.","journal-title":"Ann Clin Transl Neurol"},{"issue":"5","key":"737_CR108","doi-asserted-by":"publisher","first-page":"776","DOI":"10.3174\/ajnr.A6045","volume":"40","author":"S Suthiphosuwan","year":"2019","unstructured":"Suthiphosuwan S, Sati P, Guenette M, Montalban X, Reich DS, Bharatha A, et al. The central vein sign in radiologically isolated syndrome. Am J Neuroradiol. 2019;40(5):776\u201383.","journal-title":"Am J Neuroradiol"},{"issue":"14","key":"737_CR109","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1177\/13524585211002097","volume":"27","author":"J Oh","year":"2021","unstructured":"Oh J, Suthiphosuwan S, Sati P, Absinta M, Dewey B, Guenette M, et al. Cognitive impairment, the central vein sign, and paramagnetic rim lesions in RIS. Mult Scler J. 2021;27(14):2199\u2013208.","journal-title":"Mult Scler J"},{"key":"737_CR110","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000005256","author":"R Cortese","year":"2018","unstructured":"Cortese R, Magnollay L, Tur C, Abdel-Aziz K, Jacob A, De Angelis F, et al. Value of the central vein sign at 3T to differentiate MS from seropositive NMOSD. Neurology [Internet]. 2018. https:\/\/doi.org\/10.1212\/WNL.0000000000005256.","journal-title":"Neurology [Internet]"},{"issue":"14","key":"737_CR111","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1177\/13524585231204414","volume":"29","author":"S Sacco","year":"2023","unstructured":"Sacco S, Virupakshaiah A, Papinutto N, Schoeps VA, Akula A, Zhao H, et al. Susceptibility-based imaging aids accurate distinction of pediatric-onset MS from myelin oligodendrocyte glycoprotein antibody-associated disease. Mult Scler J. 2023;29(14):1736\u201347.","journal-title":"Mult Scler J"},{"issue":"4","key":"737_CR112","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000200253","volume":"11","author":"S Borrelli","year":"2024","unstructured":"Borrelli S, Martire MS, St\u00f6lting A, Vanden Bulcke C, Pedrini E, Guisset F, et al. Central vein sign, cortical lesions, and paramagnetic rim lesions for the diagnostic and prognostic workup of multiple sclerosis. Neurol Neuroimmunol Neuroinflamm. 2024;11(4): e200253.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"737_CR113","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2024.106182","volume":"93","author":"M Amin","year":"2025","unstructured":"Amin M, Nakamura K, Daboul L, O\u2019Donnell C, Cao Q, Rodrigues P, et al. Incorporation of the central vein sign into the McDonald criteria. Mult Scler Relat Disord. 2025;93: 106182.","journal-title":"Mult Scler Relat Disord"},{"issue":"4","key":"737_CR114","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1177\/1352458519876031","volume":"26","author":"P Maggi","year":"2020","unstructured":"Maggi P, Absinta M, Sati P, Perrotta G, Massacesi L, Dachy B, et al. The \u201ccentral vein sign\u201d in patients with diagnostic \u201cred flags\u201d for multiple sclerosis: a prospective multicenter 3T study. Mult Scler J. 2020;26(4):421\u201332.","journal-title":"Mult Scler J"},{"issue":"6","key":"737_CR115","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1177\/1352458517726383","volume":"24","author":"AJ Solomon","year":"2018","unstructured":"Solomon AJ, Watts R, Ontaneda D, Absinta M, Sati P, Reich DS. Diagnostic performance of central vein sign for multiple sclerosis with a simplified three-lesion algorithm. Mult Scler J. 2018;24(6):750\u20137.","journal-title":"Mult Scler J"},{"issue":"1","key":"737_CR116","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1177\/13524585231214360","volume":"30","author":"L Daboul","year":"2024","unstructured":"Daboul L, O\u2019Donnell CM, Amin M, Rodrigues P, Derbyshire J, Azevedo C, et al. A multicenter pilot study evaluating simplified central vein assessment for the diagnosis of multiple sclerosis. Mult Scler J. 2024;30(1):25\u201334.","journal-title":"Mult Scler J"},{"issue":"10","key":"737_CR117","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1177\/13524585241271988","volume":"30","author":"K Toljan","year":"2024","unstructured":"Toljan K, Daboul L, Raza P, Martin ML, Cao Q, O\u2019Donnell CM, et al. Diagnostic performance of central vein sign versus oligoclonal bands for multiple sclerosis. Mult Scler J. 2024;30(10):1268\u201377.","journal-title":"Mult Scler J"},{"issue":"2","key":"737_CR118","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000001120","volume":"9","author":"O Al-Louzi","year":"2022","unstructured":"Al-Louzi O, Letchuman V, Manukyan S, Beck ES, Roy S, Ohayon J, et al. Central vein sign profile of newly developing lesions in multiple sclerosis: a 3-year longitudinal study. Neurol Neuroimmunol Neuroinflamm. 2022;9(2): e1120.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"7","key":"737_CR119","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1177\/1352458520943785","volume":"27","author":"F Guisset","year":"2021","unstructured":"Guisset F, Lolli V, Bugli C, Perrotta G, Absil J, Dachy B, et al. The central vein sign in multiple sclerosis patients with vascular comorbidities. Mult Scler J. 2021;27(7):1057\u201365.","journal-title":"Mult Scler J"},{"issue":"8","key":"737_CR120","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/S1474-4422(23)00148-5","volume":"22","author":"AJ Solomon","year":"2023","unstructured":"Solomon AJ, Arrambide G, Brownlee WJ, Flanagan EP, Amato MP, Amezcua L, et al. Differential diagnosis of suspected multiple sclerosis: an updated consensus approach. Lancet Neurol. 2023;22(8):750\u201368.","journal-title":"Lancet Neurol"},{"issue":"1","key":"737_CR121","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ncl.2023.07.001","volume":"42","author":"M Kaisey","year":"2024","unstructured":"Kaisey M, Solomon AJ. Multiple sclerosis diagnostic delay and misdiagnosis. Neurol Clin. 2024;42(1):1\u201313.","journal-title":"Neurol Clin"},{"issue":"1","key":"737_CR122","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3390\/brainsci12010069","volume":"12","author":"B Chen","year":"2021","unstructured":"Chen B, Tian DS, Bu BT. A comparison of IgG index and oligoclonal band in the cerebrospinal fluid for differentiating between RRMS and NMOSD. Brain Sci. 2021;12(1):69.","journal-title":"Brain Sci"},{"key":"737_CR123","doi-asserted-by":"publisher","first-page":"104730","DOI":"10.1016\/j.msard.2023.104730","volume":"75","author":"MA Lana-Peixoto","year":"2023","unstructured":"Lana-Peixoto MA, Talim NC, Callegaro D, Marques VD, Damasceno A, Becker J, et al. Neuromyelitis optica spectrum disorders with a benign course. Analysis of 544 patients. Mult Scler Relat Disord. 2023;75:104730.","journal-title":"Mult Scler Relat Disord."},{"issue":"8","key":"737_CR124","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1111\/j.1468-1331.2004.00822.x","volume":"11","author":"A Bourahoui","year":"2004","unstructured":"Bourahoui A, De Seze J, Guttierez R, Onraed B, Hennache B, Ferriby D, et al. CSF isoelectrofocusing in a large cohort of MS and other neurological diseases. Eur J Neurol. 2004;11(8):525\u20139.","journal-title":"Eur J Neurol"},{"issue":"5","key":"737_CR125","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1007\/s00415-020-10377-6","volume":"268","author":"T Akaishi","year":"2021","unstructured":"Akaishi T, Takahashi T, Fujihara K, Misu T, Fujimori J, Takai Y, et al. Impact of comorbid Sj\u00f6gren syndrome in anti-aquaporin-4 antibody-positive neuromyelitis optica spectrum disorders. J Neurol. 2021;268(5):1938\u201344.","journal-title":"J Neurol"},{"issue":"1","key":"737_CR126","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000200329","volume":"12","author":"JD Krett","year":"2025","unstructured":"Krett JD, Filippatou AG, Barreras P, Pardo CA, Gelber AC, Sotirchos ES. \u201cLupus myelitis\u201d revisited: a retrospective single-center study of myelitis associated with rheumatologic disease. Neurol Neuroimmunol Neuroinflamm. 2025;12(1): e200329.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"737_CR127","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000201465","author":"R Cortese","year":"2023","unstructured":"Cortese R, Prados Carrasco F, Tur C, Bianchi A, Brownlee W, De Angelis F, et al. Differentiating multiple sclerosis from AQP4-neuromyelitis optica spectrum disorder and MOG-antibody disease with imaging. Neurology [Internet]. 2023. https:\/\/doi.org\/10.1212\/WNL.0000000000201465.","journal-title":"Neurology [Internet]"},{"issue":"9","key":"737_CR128","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/S1474-4422(21)00218-0","volume":"20","author":"R Marignier","year":"2021","unstructured":"Marignier R, Hacohen Y, Cobo-Calvo A, Pr\u00f6bstel AK, Aktas O, Alexopoulos H, et al. Myelin-oligodendrocyte glycoprotein antibody-associated disease. Lancet Neurol. 2021;20(9):762\u201372.","journal-title":"Lancet Neurol"},{"key":"737_CR129","doi-asserted-by":"publisher","first-page":"1237149","DOI":"10.3389\/fimmu.2023.1237149","volume":"14","author":"B Vlad","year":"2023","unstructured":"Vlad B, Reichen I, Neidhart S, Hilty M, Lekaditi D, Heuer C, et al. Basic CSF parameters and MRZ reaction help in differentiating MOG antibody-associated autoimmune disease versus multiple sclerosis. Front Immunol. 2023;14:1237149.","journal-title":"Front Immunol"},{"issue":"4","key":"737_CR130","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1136\/jnnp-2017-316286","volume":"89","author":"M Bonnan","year":"2018","unstructured":"Bonnan M, Valentino R, Debeugny S, Merle H, Ferg\u00e9 JL, Mehdaoui H, et al. Short delay to initiate plasma exchange is the strongest predictor of outcome in severe attacks of NMO spectrum disorders. J Neurol Neurosurg Psychiatry. 2018;89(4):346\u201351.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"737_CR131","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000572","volume":"6","author":"H Stiebel-Kalish","year":"2019","unstructured":"Stiebel-Kalish H, Hellmann MA, Mimouni M, Paul F, Bialer O, Bach M, et al. Does time equal vision in the acute treatment of a cohort of AQP4 and MOG optic neuritis? Neurol Neuroimmunol Neuroinflamm. 2019;6(4): e572.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"6","key":"737_CR132","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1002\/ana.20703","volume":"58","author":"CH Polman","year":"2005","unstructured":"Polman CH, Reingold SC, Edan G, Filippi M, Hartung H, Kappos L, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the \u201cMcDonald Criteria.\u201d Ann Neurol. 2005;58(6):840\u20136.","journal-title":"Ann Neurol"},{"key":"737_CR133","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.cca.2018.12.006","volume":"489","author":"A Emersic","year":"2019","unstructured":"Emersic A, Anadolli V, Krsnik M, Rot U. Intrathecal immunoglobulin synthesis: the potential value of an adjunct test. Clin Chim Acta. 2019;489:109\u201316.","journal-title":"Clin Chim Acta"},{"issue":"12","key":"737_CR134","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1177\/1352458515624975","volume":"22","author":"IC George","year":"2016","unstructured":"George IC, Sati P, Absinta M, Cortese IC, Sweeney EM, Shea CD, et al. Clinical 3-tesla FLAIR* MRI improves diagnostic accuracy in multiple sclerosis. Mult Scler J. 2016;22(12):1578\u201386.","journal-title":"Mult Scler J"},{"issue":"4","key":"737_CR135","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1177\/1352458519882282","volume":"26","author":"MA Clarke","year":"2020","unstructured":"Clarke MA, Samaraweera AP, Falah Y, Pitiot A, Allen CM, Dineen RA, et al. Single Test to ARrive at Multiple Sclerosis (STAR-MS) diagnosis: a prospective pilot study assessing the accuracy of the central vein sign in predicting multiple sclerosis in cases of diagnostic uncertainty. Mult Scler J. 2020;26(4):433\u201341.","journal-title":"Mult Scler J"}],"container-title":["Neurology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40120-025-00737-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40120-025-00737-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40120-025-00737-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T11:03:32Z","timestamp":1747652612000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40120-025-00737-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,6]]},"references-count":135,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["737"],"URL":"https:\/\/doi.org\/10.1007\/s40120-025-00737-7","relation":{},"ISSN":["2193-8253","2193-6536"],"issn-type":[{"value":"2193-8253","type":"print"},{"value":"2193-6536","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,6]]},"assertion":[{"value":"25 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Michael Levraut, Cassandre Landes-Chateau, Mikael Cohen, and Lydiane Mondot have nothing to disclose related to this study. Christine Lebrun-Frenay was part of the expert panel that reviewed and proposed the 2024 update of the McDonald criteria.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Patients' consent was obtained for their MR images to be published anonymously.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient Consent"}}]}}